CPT 88377Laboratory

M/phmtrc alys ishquant/semiq

CPT 88377 covers computerized morphometric analysis of tumor cells or tissue, where a pathologist uses specialized software to measure and analyze cell characteristics semi-quantitatively or with limited quantitative features.

Showing rates for

National Average

Base Medicare rate

$376.19

This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.

RVU breakdown

Work RVU

1.4

PE RVU (NF)

10.19

MP RVU

0.04

Total RVU

11.63

Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High

NCCI bundling edits

Loading bundling edits…

Billing tips

Document the specific morphometric parameters measured (nuclear area, perimeter, shape factors, optical density) and the image analysis software/platform used
Impact: Reduces denial risk by 40-50%; auditors frequently deny claims lacking specific methodology documentation, resulting in loss of the full $376.19 payment
Bill only once per specimen/slide analyzed, regardless of how many fields or cells are measured, unless analyzing distinctly different tumor areas with modifier 59
Impact: Prevents overbilling denials and recoupment; improper multiple billing can trigger comprehensive audits of 12+ months of claims
Ensure the morphometric analysis is distinct from routine microscopic examination (88300-88309 series) and not already included in the surgical pathology service
Impact: Prevents bundling denials worth $376.19 per occurrence; some payers consider basic image analysis part of routine examination
Verify LCD (Local Coverage Determination) requirements for your MAC regarding which tumor types and biomarkers qualify for semi-quantitative morphometric analysis
Impact: Prevents medical necessity denials; non-covered indications result in 100% payment denial plus potential patient billing restrictions
Link appropriate ICD-10 codes specifying the neoplasm site and behavior (malignant, in-situ, uncertain) to support medical necessity
Impact: Increases clean claim rate by 25-30%; vague or unspecified neoplasm codes trigger automatic medical review and payment delays
Distinguish CPT 88377 (semi-quantitative) from 88361 (manual quantitative) and 88373 (in-situ hybridization) by clearly documenting the computer-assisted methodology

Live Field Datano reports yet

Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.

Working with CPT 88377?

Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.

Help build the field knowledge

MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.

Related actions

Frequently asked questions

What is CPT code 88377 used for in pathology billing?

CPT 88377 is used to bill for morphometric analysis using computer-assisted semi-quantitative or limited quantitative techniques on tissue specimens. This involves specialized image analysis software that objectively measures cellular or nuclear features (size, shape, staining intensity) to help diagnose cancer, determine prognosis, or guide treatment decisions. The 2025 Medicare payment is $376.19.

How much does Medicare pay for CPT 88377 in 2025?

Medicare pays $376.19 for CPT 88377 in 2025 under the national average physician fee schedule rate. This applies to both facility and non-facility settings. The total RVU is 11.63, multiplied by the 2025 conversion factor of 32.3465. Actual payment may vary by geographic locality and payer contract.

What is the difference between CPT 88377 and 88361?

CPT 88377 covers computer-assisted semi-quantitative morphometric analysis, while CPT 88361 is for manual morphometric analysis using fully quantitative techniques. 88377 requires specialized image analysis software and produces objective measurements with limited quantitation, whereas 88361 involves manual counting and measurement. The methodology used (computer vs. manual) determines the correct code assignment.

Can CPT 88377 be billed with surgical pathology codes?

Yes, CPT 88377 can be billed separately from surgical pathology codes (88300-88309 series) when morphometric analysis is a distinct additional service beyond routine microscopic examination. Documentation must clearly show the computer-assisted quantitative analysis was performed as a separate procedure requiring specialized equipment and additional interpretation. Some payers may require modifier 59 to prevent bundling.

What documentation is required to bill CPT 88377?

Required documentation includes: specimen identification, specific biomarker analyzed, image analysis software name/version, morphometric parameters measured, number of cells/fields analyzed, quantitative results with units, quality control data, pathologist interpretation of clinical significance, and clear statement that computer-assisted methodology was used. Missing any of these elements significantly increases denial risk.

How many RVUs is CPT code 88377 worth in 2025?

CPT 88377 has a total RVU value of 11.63 in 2025, consisting of 1.4 work RVUs, 10.19 practice expense RVUs (both facility and non-facility), and 0.04 malpractice RVUs. The high practice expense RVU reflects the significant equipment and technical staff costs associated with computerized image analysis systems.

What are common denial reasons for CPT 88377?

Common denials include lack of medical necessity documentation, bundling with surgical pathology services, insufficient documentation of computer-assisted semi-quantitative methodology, and duplicate billing when multiple units are submitted. Success rates improve significantly when the pathology report specifically details the image analysis software used and quantitative parameters measured, along with clinical justification for why the analysis was necessary.